Penn-Coordinated Study Confirms Long-Term Benefit of Anti-VEGF Therapy for Age-Related Macular Degeneration
Perelman School of Medicine at the University of PennsylvaniaPatients with age-related macular degeneration (AMD), the most common cause of major vision loss in older people, still show benefits from a new class of therapy -- originally developed to treat cancer -- after long-term treatment.